NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data Studio, a unified experience that unlocks the true power of clinical research data. This groundbreaking technology gives stakeholders greater control over the quality of data and the ability to deliver safer trials to patients faster..

纽约--（商业新闻短讯）--达索系统公司（Dassault Systèmes）品牌和生命科学行业临床试验解决方案的领先供应商Medidata今天宣布推出Medidata clinical Data Studio，这是一种统一的体验，可以释放临床研究数据的真正力量。这种开创性的技术使利益相关者能够更好地控制数据质量，并能够更快地为患者提供更安全的试验。。

Built on the Medidata Platform, Clinical Data Studio integrates data from both Medidata and non-Medidata sources, accelerating decision-making across the full clinical trial process and delivering holistic data and risk strategies that connect patients, sites, and sponsors. Through AI, study teams can more effectively identify potential data issues and safety signals, resulting in a more accurate understanding of the patient.

Clinical Data Studio建立在Medidata平台上，整合了Medidata和非Medidata来源的数据，加速了整个临床试验过程中的决策，并提供了连接患者，站点和赞助商的整体数据和风险策略。。

This reduces the challenges posed by siloed data systems and enables action data review and reconciliation up to 80 percent faster..

这减少了孤立数据系统带来的挑战，使行动数据审查和协调速度提高了80%。。

“Clinical Data Studio unlocks the broad ecosystem of clinical data. Powered by embedded AI, we are democratizing access to data and revealing the signals, risks, and insights that matter most. Together this accelerates trial execution and creates rich data for new discoveries,” said Tom Doyle, chief technology officer, Medidata..

Medidata首席技术官汤姆·道尔（TomDoyle）表示：“临床数据工作室（Clinical Data Studio）开启了广泛的临床数据生态系统。在嵌入式人工智能的支持下，我们正在实现数据访问的民主化，并揭示最重要的信号、风险和见解。这共同加速了试验的执行，并为新发现创造了丰富的数据。”。。

Clinical Data Studio offers a comprehensive workspace for data integration, transformation, and management. It includes AI-assisted data reconciliation and anomaly detection, self-serve data listings, robust risk-based quality management, and tools to implement a holistic data and risk strategy supported by workflows and visualizations..

Clinical Data Studio为数据集成、转换和管理提供了一个全面的工作空间。它包括人工智能辅助的数据协调和异常检测、自助服务数据列表、强大的基于风险的质量管理，以及实施由工作流和可视化支持的整体数据和风险策略的工具。。

“As data volume and sources grow exponentially, managing this data and garnering real-time insights is becoming increasingly complex. Not only is this impacting time-to-market, but it is also delaying the timely delivery of therapies to patients, thus impacting patients' lives,' said Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology, IDC.

IDC生命科学研发战略与技术研究副总裁尼米塔·利马耶博士说：“随着数据量和数据来源呈指数级增长，管理这些数据和获取实时见解变得越来越复杂。这不仅影响了上市时间，而且还延迟了向患者及时提供治疗，从而影响了患者的生活。”。

“By enabling users to manage all their data, both Medidata and non-Medidata data, in one place, Medidata Clinical Data Studio has the potential to disrupt the industry by accelerating clinical trials and getting therapies to patients faster.”.

“通过使用户能够在一个地方管理所有数据，包括Medidata和非Medidata数据，Medidata Clinical data Studio有可能通过加速临床试验和更快地为患者提供治疗来扰乱行业。”。

About Medidata

关于Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world.

Medidata通过数字解决方案支持临床试验，为更智能的治疗和更健康的人群提供动力。Medidata在超过33000项试验和1000万名患者中进行了25年的突破性技术创新，提供了业界领先的专业知识、分析支持的见解以及世界上最大的患者级历史临床试验数据集。

More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC.

2200多名客户中有100多万注册用户信任Medidata的无缝端到端平台，以改善患者体验，加速临床突破，并更快地将疗法推向市场。作为达索Systèmes品牌（巴黎泛欧交易所：FR0014003TT8，DSY.PA），Medidata总部位于纽约市，已被Everest Group和IDC公认为领导者。

Discover more at www.medidata.com and follow us @Medidata..

请访问www.medidata.com了解更多信息，并关注我们@medidata。。

About Dassault Systèmes

关于达索系统

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable.

达索系统是人类进步的催化剂。我们为企业和人们提供协作虚拟环境，以想象可持续的创新。通过我们的3DEXPERIENCE平台和应用程序创建真实世界的虚拟双胞胎体验，我们的客户可以重新定义其产品的创建、生产和生命周期管理流程，从而产生有意义的影响，使世界更加可持续。

The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.

体验经济的美妙之处在于它是一种以人为本的经济，造福于所有人——消费者、患者和公民。达索系统为150多个国家的所有行业的350000多个不同规模的客户带来了价值。有关详细信息，请访问www.3ds.com。

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries.

©达索系统。保留所有权利。3DEXPERIENCE、3DS徽标、指南针图标、IFWE、3DEXCITE、3DVIA、BIOVIA、CATIA、CENTRIC PLM、DELMIA、ENOVIA、GEOVIA、MEDIDATA、NETVIBES、OUTSCALE、SIMULIA和SOLIDWORKS是达索系统（Dassault Systèmes）的商业商标或注册商标，达索系统是一家根据法国法律成立的欧洲公司（Societas Europaea），并在凡尔赛贸易和公司注册处注册，注册号为322 306 440，或其在美国和/或其他国家的子公司。

All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval..

所有其他商标均归其各自所有者所有。使用达索Systèmes或其子公司的任何商标均须获得其明确的书面批准。。